Feb 25 (Reuters) – Sarepta Therapeutics CEO Douglas Ingram has decided to step down by the end of 2026 or upon the appointment of his replacement, the company said in a regulatory filing.
The company said it has commenced a search for his replacement.
(Reporting by Sneha S K; Editing by Shinjini Ganguli)
Comments